Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY: BDX )

247.23 +2.06 (+0.84%)
Streaming Delayed Price Updated: 11:18 AM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 201,517
Open 246.49
Bid (Size) 247.17 (1)
Ask (Size) 247.32 (4)
Prev. Close 245.17
Today's Range 244.25 - 247.23
52wk Range 215.90 - 277.29
Shares Outstanding 287,190,180
Dividend Yield 1.34%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Dividend Aristocrats to Buy for Consistent Income Growth
The dividend aristocrats each provide consistent income growth over the long-term that those seeking passive income can rely on. 
Via InvestorPlace
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
These three spinoffs are already profitable. 
Via The Motley Fool

Performance

YTD
-3.49%
-3.49%
1 Month
+5.41%
+5.41%
3 Month
-3.76%
-3.76%
6 Month
+9.34%
+9.34%
1 Year
-8.29%
-8.29%

More News

Read More
Healthcare Stocks With at Least 30 Years of Dividend Increases
Via MarketBeat
3 Stocks To Buy For Consistent Dividend Growth
Via Talk Markets
Becton, Dickinson's Debt Overview
Via Benzinga
(BDX) - Analyzing Becton, Dickinson's Short Interest
Via Benzinga
Looking Into Becton's Return On Capital Employed
Via Benzinga
What 6 Analyst Ratings Have To Say About Becton, Dickinson
Via Benzinga
A Bullish Sign Appears On Becton, Dickinson's Chart
Via Benzinga
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via TheNewswire.com
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via Benzinga
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
What 6 Analyst Ratings Have To Say About Becton, Dickinson
Via Benzinga
The 7 Best Dividend Growth Stocks for Long-Term Investors
Via InvestorPlace
Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software
Via Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
Via Benzinga
Why Embecta Stock Popped by Nearly 13% Today
Via The Motley Fool
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via TheNewswire.com
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via News Direct
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via Benzinga
Becton Dickinson, Freeport-McMoRan, GXO Logistics And This Mid-Cap ETF On CNBC's 'Final Trades'
Via Benzinga
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
Via Benzinga
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
Via FinancialNewsMedia
Exposures COVID-19
2 Relatively Safe Dividend Stocks to Buy Today and Hold Forever
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.